Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988;95(3):381-5.
doi: 10.1007/BF00181952.

Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats

Affiliations

Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats

R Dall'Olio et al. Psychopharmacology (Berl). 1988.

Abstract

The selective D1 receptor stimulant SKF 38393 dose-dependently increased grooming time in rats without affecting locomotor activity or eliciting stereotyped behaviour. The selective D2 receptor agonist LY 171555 induced a dose-dependent increase in rat motility, a marked decrease in grooming time and a low occurrence of stereotyped behaviour. Concurrent administration of the two selective agonists induced high-degree stereotyped responses and reductions in locomotor and grooming behaviours. Rats withdrawn from repeated treatment with the selective D1 receptor blocker SCH 23390 (0.05 mg/kg twice daily for 21 days; 7 days of washout) did not exhibit any change of locomotor and grooming responses to threshold doses of LY 171555 and SKF 38393 given alone or in combination. On the contrary, a significantly greater occurrence of high-degree stereotyped responses to the combination of the two selective agonists was observed. The data support the view that D1 and D2 receptors have a cooperative role in the generation of stereotypies and suggest that D1 receptor supersensitivity needs D2 stimulation to be revealed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Psychopharmacology (Berl). 1984;82(4):409-10 - PubMed
    1. Neuropharmacology. 1986 Aug;25(8):947-9 - PubMed
    1. Psychopharmacology (Berl). 1987;91(3):394-6 - PubMed
    1. Eur J Pharmacol. 1985 Feb 12;109(1):127-8 - PubMed
    1. Eur J Pharmacol. 1985 Jul 11;113(1):109-14 - PubMed

Publication types

MeSH terms

LinkOut - more resources